In this study, women with ER-/HER2/neu+/Ki67+ DCIS had a greater risk of developing DCIS recurrence than women with other expression profiles (Kerlikowske et al, 2010). This evidence concerns the gene MKI67 and ductal breast carcinoma in situ.